A team of researchers from Australia has developed a promising new approach to treating myelofibrosis, a rare and serious form of blood cancer. This condition interferes with the body’s ability to produce healthy blood cells, often leading to symptoms such as fatigue, pain, an enlarged spleen, and a decreased quality of life. Currently available treatments only alleviate symptoms, with no known cure for the disease.
Published in the journal Blood, the study shifts focus from merely managing symptoms to targeting the abnormal blood cells that drive myelofibrosis through immunotherapy. “Patients with myelofibrosis typically receive treatments aimed at controlling symptoms without specifically targeting the abnormal cells responsible for the disease,” explained Professor Daniel Thomas, director of the Blood Cancer programme at the South Australian Health and Medical Research Institute (SAHMRI). He emphasized that their research indicates the potential to create therapies that are more effective and precisely targeted by concentrating on the unique characteristics of these abnormal cells, marking a significant shift in myelofibrosis treatment.
Utilizing cells from affected patients, the research team identified two optimal targets that can effectively eliminate the problematic cells. This study underscores the potential of precision immunology, which enables the immune system to recognize and attack disease-causing cells while sparing healthy ones. The findings suggest that various biological forms of myelofibrosis might benefit from tailored treatment strategies.
“The future of cancer treatment lies in comprehending the disease at both the molecular and immune levels, and then applying that understanding to create therapies that are potent, long-lasting, and precise,” noted Angel Lopez, head of Human Immunology at SA Pathology. While these findings show great promise, additional research and clinical development are necessary before this approach can be tested on patients.
Original Source: https://www.morungexpress.com/australian-researchers-develop-targeted-therapy-for-rare-blood-cancer
Category: Health
Tags:
Publish Date: 2026-01-12 12:53:00
